| UniProt ID | NAA50_HUMAN | |
|---|---|---|
| UniProt AC | Q9GZZ1 | |
| Protein Name | N-alpha-acetyltransferase 50 {ECO:0000305} | |
| Gene Name | NAA50 {ECO:0000312|HGNC:HGNC:29533} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 169 | |
| Subcellular Localization | Cytoplasm . Nucleus . Localizes to the cytoplasm in interphase cells (PubMed:17502424). | |
| Protein Description | N-alpha-acetyltransferase that acetylates the N-terminus of proteins that retain their initiating methionine. [PubMed: 19744929] | |
| Protein Sequence | MKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Ubiquitination | ------MKGSRIELG ------CCCCCEECC | 66.64 | - | |
| 4 | Phosphorylation | ----MKGSRIELGDV ----CCCCCEECCCC | 25.27 | 25056879 | |
| 12 | Phosphorylation | RIELGDVTPHNIKQL CEECCCCCHHCHHHH | 24.46 | 25159151 | |
| 17 | Ubiquitination | DVTPHNIKQLKRLNQ CCCHHCHHHHHHHCC | 55.70 | 21890473 | |
| 17 (in isoform 2) | Ubiquitination | - | 55.70 | 21890473 | |
| 17 (in isoform 1) | Ubiquitination | - | 55.70 | 21890473 | |
| 17 | Acetylation | DVTPHNIKQLKRLNQ CCCHHCHHHHHHHCC | 55.70 | 25953088 | |
| 17 | Malonylation | DVTPHNIKQLKRLNQ CCCHHCHHHHHHHCC | 55.70 | 26320211 | |
| 20 | Ubiquitination | PHNIKQLKRLNQVIF HHCHHHHHHHCCEEE | 52.96 | - | |
| 20 (in isoform 2) | Ubiquitination | - | 52.96 | - | |
| 30 | Phosphorylation | NQVIFPVSYNDKFYK CCEEEEECCCCHHHH | 20.61 | 20068231 | |
| 31 | Phosphorylation | QVIFPVSYNDKFYKD CEEEEECCCCHHHHH | 27.84 | 20068231 | |
| 34 (in isoform 1) | Ubiquitination | - | 47.13 | 21890473 | |
| 34 | Acetylation | FPVSYNDKFYKDVLE EEECCCCHHHHHHHH | 47.13 | 19608861 | |
| 34 (in isoform 2) | Ubiquitination | - | 47.13 | 21890473 | |
| 34 (in isoform 2) | Acetylation | - | 47.13 | 19608861 | |
| 34 | Ubiquitination | FPVSYNDKFYKDVLE EEECCCCHHHHHHHH | 47.13 | 19608861 | |
| 36 (in isoform 2) | Phosphorylation | - | 16.42 | - | |
| 37 | Ubiquitination | SYNDKFYKDVLEVGE CCCCHHHHHHHHHHH | 44.48 | 19608861 | |
| 37 (in isoform 1) | Ubiquitination | - | 44.48 | 21890473 | |
| 37 | Acetylation | SYNDKFYKDVLEVGE CCCCHHHHHHHHHHH | 44.48 | 19608861 | |
| 38 (in isoform 2) | Ubiquitination | - | 38.56 | 21890473 | |
| 47 | Ubiquitination | LEVGELAKLAYFNDI HHHHHHHHHHHCCCC | 46.40 | - | |
| 47 (in isoform 2) | Ubiquitination | - | 46.40 | 21890473 | |
| 50 | Phosphorylation | GELAKLAYFNDIAVG HHHHHHHHCCCCCEE | 17.22 | 28152594 | |
| 64 (in isoform 2) | Ubiquitination | - | 19.17 | 21890473 | |
| 70 | 2-Hydroxyisobutyrylation | VDHSQNQKRLYIMTL CCCCCCCEEEEEEEH | 52.50 | - | |
| 73 | Phosphorylation | SQNQKRLYIMTLGCL CCCCEEEEEEEHHHH | 7.84 | - | |
| 78 (in isoform 2) | Ubiquitination | - | 8.67 | 21890473 | |
| 91 | Ubiquitination | RRLGIGTKMLNHVLN HHCCCCHHHHHHHHH | 35.86 | 20639865 | |
| 91 | Acetylation | RRLGIGTKMLNHVLN HHCCCCHHHHHHHHH | 35.86 | 25953088 | |
| 110 | Phosphorylation | DGTFDNIYLHVQISN CCCCCCEEEEEEECC | 9.30 | 22817900 | |
| 126 | Acetylation | SAIDFYRKFGFEIIE HHHHHHHHHCCEEEE | 38.16 | 25953088 | |
| 126 | Ubiquitination | SAIDFYRKFGFEIIE HHHHHHHHHCCEEEE | 38.16 | 21890473 | |
| 135 | Acetylation | GFEIIETKKNYYKRI CCEEEEECCCHHHHC | 26.65 | 25953088 | |
| 135 | Ubiquitination | GFEIIETKKNYYKRI CCEEEEECCCHHHHC | 26.65 | 2190698 | |
| 135 (in isoform 1) | Ubiquitination | - | 26.65 | 21890473 | |
| 136 | Ubiquitination | FEIIETKKNYYKRIE CEEEEECCCHHHHCC | 58.56 | - | |
| 139 | Phosphorylation | IETKKNYYKRIEPAD EEECCCHHHHCCHHH | 11.81 | - | |
| 140 | Acetylation | ETKKNYYKRIEPADA EECCCHHHHCCHHHC | 36.22 | 19744929 | |
| 140 | Ubiquitination | ETKKNYYKRIEPADA EECCCHHHHCCHHHC | 36.22 | 19744929 | |
| 152 (in isoform 1) | Ubiquitination | - | 61.15 | 21890473 | |
| 152 | Acetylation | ADAHVLQKNLKVPSG HHCHHHHHCCCCCCC | 61.15 | 19608861 | |
| 152 | Ubiquitination | ADAHVLQKNLKVPSG HHCHHHHHCCCCCCC | 61.15 | 21890473 | |
| 155 | Ubiquitination | HVLQKNLKVPSGQNA HHHHHCCCCCCCCCC | 62.59 | - | |
| 166 (in isoform 1) | Ubiquitination | - | 58.66 | 21890473 | |
| 166 | Ubiquitination | GQNADVQKTDN---- CCCCCCCCCCC---- | 58.66 | - | |
| 167 | Phosphorylation | QNADVQKTDN----- CCCCCCCCCC----- | 24.55 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NAA50_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NAA50_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NAA50_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NAA15_HUMAN | NAA15 | physical | 16507339 | |
| NAA10_HUMAN | NAA10 | physical | 16507339 | |
| DNJC7_HUMAN | DNAJC7 | physical | 26344197 | |
| HNRPD_HUMAN | HNRNPD | physical | 26344197 | |
| HNRDL_HUMAN | HNRNPDL | physical | 26344197 | |
| NDRG1_HUMAN | NDRG1 | physical | 26344197 | |
| TIM8B_HUMAN | TIMM8B | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-34 AND LYS-37, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-12, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-110, AND MASSSPECTROMETRY. | |